• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物医学应用的刺激响应性脂质体。

Stimulus-responsive liposomes for biomedical applications.

机构信息

Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, Milano 20133, Italy.

Dipartimento di Scienze farmaceutiche, DISFARM, Università degli Studi di Milano, Via Venezian 21, Milano 20133, Italy.

出版信息

Drug Discov Today. 2021 Aug;26(8):1794-1824. doi: 10.1016/j.drudis.2021.05.010. Epub 2021 May 29.

DOI:10.1016/j.drudis.2021.05.010
PMID:34058372
Abstract

Liposomes are amphipathic lipidic supramolecular aggregates that are able to encapsulate and carry molecules of both hydrophilic and hydrophobic nature. They have been widely used as in vivo drug delivery systems for some time because they offer features such as synthetic flexibility, biodegradability, biocompatibility, low immunogenicity, and negligible toxicity. In recent years, the chemical modification of liposomes has paved the way to the development of smart liposome-based drug delivery systems, which are characterized by even more tunable and disease-directed features. In this review, we highlight the different types of chemical modification introduced to date, with a particular focus on internal stimuli-responsive liposomes and prodrug activation.

摘要

脂质体是两亲性脂质超分子聚集体,能够包裹和携带亲水和疏水性质的分子。它们已被广泛用作体内药物传递系统一段时间,因为它们具有合成灵活性、生物降解性、生物相容性、低免疫原性和几乎无毒的特性。近年来,脂质体的化学修饰为智能脂质体药物传递系统的发展铺平了道路,这些系统具有更可调谐和针对疾病的特征。在这篇综述中,我们重点介绍了迄今为止引入的不同类型的化学修饰,特别是内部刺激响应脂质体和前药激活。

相似文献

1
Stimulus-responsive liposomes for biomedical applications.用于生物医学应用的刺激响应性脂质体。
Drug Discov Today. 2021 Aug;26(8):1794-1824. doi: 10.1016/j.drudis.2021.05.010. Epub 2021 May 29.
2
Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches.高级脂质体和聚合物囊泡药物输送系统:理化性质、靶向策略和刺激响应方法的考虑因素。
Adv Colloid Interface Sci. 2023 Jul;317:102930. doi: 10.1016/j.cis.2023.102930. Epub 2023 May 29.
3
Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.刺激响应性脂质体作为用于药物递送应用的智能纳米平台。
Nanotechnol Rev. 2018 Feb;7(1):95-122. doi: 10.1515/ntrev-2017-0154. Epub 2017 Dec 12.
4
Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.光响应性和双靶向脂质体:从机制到靶向策略。
Molecules. 2024 Jan 30;29(3):636. doi: 10.3390/molecules29030636.
5
Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.基于脂质体载体的癌症治疗响应性药物递送研究进展
Pharmaceutics. 2022 Oct 15;14(10):2195. doi: 10.3390/pharmaceutics14102195.
6
Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.白蛋白囊泡:一种新型药物传递载体,将疏水性药物包封在内水核中。
J Pharm Sci. 2018 Jan;107(1):436-445. doi: 10.1016/j.xphs.2017.08.003. Epub 2017 Aug 18.
7
Polydopamine-Modified Liposomes: Preparation and Recent Applications in the Biomedical Field.聚多巴胺修饰脂质体:制备及其在生物医学领域的最新应用
ACS Omega. 2024 May 28;9(23):24105-24120. doi: 10.1021/acsomega.4c02555. eCollection 2024 Jun 11.
8
Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery.用于癌症药物递送的刺激响应靶向脂质体制剂的最新进展
Pharm Nanotechnol. 2022;10(1):3-23. doi: 10.2174/2211738510666220214102626.
9
(Macro)molecular self-assembly for hydrogel drug delivery.用于水凝胶药物输送的(宏观)分子自组装。
Adv Drug Deliv Rev. 2021 May;172:275-295. doi: 10.1016/j.addr.2021.01.006. Epub 2021 Jan 12.
10
Liposome-ligand conjugates: a review on the current state of art.脂质体配体偶联物:综述当前的研究进展。
J Drug Target. 2020 Mar;28(3):225-244. doi: 10.1080/1061186X.2019.1648479. Epub 2019 Aug 13.

引用本文的文献

1
Encapsulation of doxorubicin in magnesium acetate liposomes as a pH-sensitive drug carrier for tumor therapy.作为用于肿瘤治疗的pH敏感药物载体的醋酸镁脂质体包裹阿霉素。
iScience. 2025 Aug 9;28(9):113336. doi: 10.1016/j.isci.2025.113336. eCollection 2025 Sep 19.
2
Nanocarrier-Based Systems for Targeted Delivery: Current Challenges and Future Directions.基于纳米载体的靶向递送系统:当前挑战与未来方向
MedComm (2020). 2025 Aug 21;6(9):e70337. doi: 10.1002/mco2.70337. eCollection 2025 Sep.
3
Targeted Drug Delivery for Breast Cancer using Functionalized Liposomes: Preparation Methods, Challenges, and Clinical Translation.
使用功能化脂质体的乳腺癌靶向给药:制备方法、挑战及临床转化
AAPS PharmSciTech. 2025 Aug 5;26(7):207. doi: 10.1208/s12249-025-03206-4.
4
pH-Sensitive Multiliposomal Containers for Encapsulation and Rapid Release of Bioactive Substances.用于生物活性物质包封与快速释放的pH敏感多层脂质体容器
Molecules. 2025 Jun 16;30(12):2608. doi: 10.3390/molecules30122608.
5
Automated fluorine-18 radiolabeling via an alkyne-azide cycloaddition reaction on a dual peptide-functionalized liposome surface for PET imaging.通过炔烃-叠氮环加成反应在双肽功能化脂质体表面进行自动化氟-18放射性标记用于正电子发射断层显像(PET)成像。
Front Pharmacol. 2025 Apr 28;16:1566257. doi: 10.3389/fphar.2025.1566257. eCollection 2025.
6
A pH-Responsive Dendritic-DNA-Based Nanohydrogel for Dual Drug Delivery.一种用于双重药物递送的基于pH响应性树枝状DNA的纳米水凝胶。
Biomolecules. 2025 Apr 6;15(4):537. doi: 10.3390/biom15040537.
7
Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers.癌症治疗的创新:内源性刺激响应脂质体作为先进的纳米载体
Pharmaceutics. 2025 Feb 13;17(2):245. doi: 10.3390/pharmaceutics17020245.
8
Chemical Communication between Giant Vesicles and Gated Nanoparticles for Strip-Based Sensing.用于条带式传感的巨囊泡与栅控纳米颗粒之间的化学通讯。
Nano Lett. 2024 Nov 6;24(44):14050-14057. doi: 10.1021/acs.nanolett.4c04022. Epub 2024 Oct 23.
9
Characterization of lipid-based nanomedicines at the single-particle level.单颗粒水平脂质基纳米药物的表征
Fundam Res. 2022 Oct 3;3(4):488-504. doi: 10.1016/j.fmre.2022.09.011. eCollection 2023 Jul.
10
Tumor-Targeted cRGD-Coated Liposomes Encapsulating Optimized Synergistic Cepharanthine and IR783 for Chemotherapy and Photothermal Therapy.载优化协同塞拉嗪和 IR783 的肿瘤靶向 cRGD 涂层脂质体用于化疗和光热治疗。
Int J Nanomedicine. 2024 Jun 19;19:6145-6160. doi: 10.2147/IJN.S457008. eCollection 2024.